Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alfa-2a

C D Williams1, D C Linch

  • 1Department of Haematology, University College London Hospitals.

British Journal of Hospital Medicine
|May 7, 1997
PubMed
Summary
This summary is machine-generated.

Interferon alfa-2a has antiviral and antitumoral effects, proving effective for hepatitis B, hepatitis C, Kaposi

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing Deficit Accumulation Among Gulf War Era Veterans.

The Journal of frailty & aging·2024
Same author

Self-reported gastrointestinal disorders among veterans with gulf war illness with and without posttraumatic stress disorder.

Neurogastroenterology and motility·2023
Same author

Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval.

Drugs·2022
Same author

Correction: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways.

Leukemia·2021
Same author

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Spatial Scale and Structural Heterogeneity in Skeletal Muscle Performance.

Integrative and comparative biology·2018
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Area of Science:

  • Immunology and Virology
  • Oncology and Hematology

Background:

  • Interferon alfa-2a exhibits documented antiviral and antitumoral properties.
  • Its therapeutic applications in various diseases are subjects of ongoing debate and research.

Purpose of the Study:

  • To review the established and controversial roles of interferon alfa-2a in clinical practice.
  • To highlight its efficacy in specific oncological and viral conditions.
  • To identify areas requiring further investigation, particularly regarding optimal dosing.

Main Methods:

  • Review of existing clinical data and therapeutic guidelines.
  • Analysis of treatment outcomes for conditions where interferon alfa-2a is indicated.
  • Identification of knowledge gaps concerning dosage and efficacy.

Related Experiment Videos

Main Results:

  • Interferon alfa-2a is the standard treatment for chronic active hepatitis B, chronic hepatitis C, and AIDS-related Kaposi's sarcoma.
  • It demonstrates effectiveness in treating metastatic renal carcinoma and chronic myelogenous leukemia.
  • Optimal dosage regimens for interferon alfa-2a are not clearly defined across all indications.

Conclusions:

  • Interferon alfa-2a is a critical therapeutic agent for specific viral infections and cancers.
  • Further randomized controlled trials are essential to establish optimal dosing strategies.
  • Continued research is needed to fully elucidate its role and refine treatment protocols.